If you read the report it's about 3 years. However, there should be significant price rises before then. I personally think the price target is considerably optomistic.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025